Navigation Links
Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
Date:8/21/2008

LAKE FOREST, Ill., Aug. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced new national agreements with Premier Purchasing Partners. The multi-year contracts will provide Premier's 2,000 member hospitals with access to special pricing and terms pre-negotiated by Premier for Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals, drug-delivery and gravity administration sets. The five-year Premier agreements will be effective February 1, 2009.

"Premier shares our commitment to improving patient and caregiver safety, while reducing the high costs of healthcare," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "Hospira products and services are well positioned to deliver positive results in these critical areas for the Premier membership. We look forward to collaborating with Premier's member healthcare institutions to provide innovative solutions and drive results."

The new agreements include Hospira's general-purpose medication management technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software; and pain management pumps, such as LifeCare PCA(R) with Hospira MedNet and GemStar(R) ambulatory devices. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. Also covered within the agreement is access to contracts for Hospira's I.V. solutions and associated equipment portfolio, including the company's environmentally preferable VisIV(R) container. This represents the first opportunity for Hospira to offer these full product lines to Premier member healthcare institutions on contract.

About Premier Inc., 2006 Malcolm Baldrige National Quality Award recipient

Serving more than 2,000 U.S. hospitals and 53,000-plus other healthcare sites, the Premier healthcare alliance and its members are transforming healthcare together. Owned by not-for-profit hospitals, Premier operates one of the leading healthcare purchasing networks and the nation's most comprehensive repository of hospital clinical and financial information. A subsidiary operates one of the nation's largest policy-holder owned, hospital professional liability risk-retention groups. A world leader in helping healthcare providers deliver dramatic improvements in care, Premier is working with the United Kingdom's National Health Service North West and the Centers for Medicare & Medicaid Services to improve hospital performance. Headquartered in San Diego, Premier has offices in Charlotte, N.C., Philadelphia and Washington. For more information, visit http://www.premierinc.com.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira Reports Second-Quarter 2008 Results
2. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
3. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
4. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
5. Hospira Acquires Sculptor
6. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
7. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira Launches Generic Irinotecan Injection
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology: